HK1208809A1 - Compositions and methods for enhancing the efficacy of contraceptive microbicides - Google Patents

Compositions and methods for enhancing the efficacy of contraceptive microbicides

Info

Publication number
HK1208809A1
HK1208809A1 HK15109540.9A HK15109540A HK1208809A1 HK 1208809 A1 HK1208809 A1 HK 1208809A1 HK 15109540 A HK15109540 A HK 15109540A HK 1208809 A1 HK1208809 A1 HK 1208809A1
Authority
HK
Hong Kong
Prior art keywords
efficacy
enhancing
compositions
methods
microbicides
Prior art date
Application number
HK15109540.9A
Other languages
English (en)
Chinese (zh)
Inventor
Wendell Guthrie
Original Assignee
Evofem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49758600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1208809(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evofem Inc filed Critical Evofem Inc
Publication of HK1208809A1 publication Critical patent/HK1208809A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
HK15109540.9A 2012-06-13 2015-09-29 Compositions and methods for enhancing the efficacy of contraceptive microbicides HK1208809A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261659368P 2012-06-13 2012-06-13
PCT/US2013/032510 WO2013187984A1 (en) 2012-06-13 2013-03-15 Compositions and methods for enhancing the efficacy of contraceptive microbicides

Publications (1)

Publication Number Publication Date
HK1208809A1 true HK1208809A1 (en) 2016-03-18

Family

ID=49758600

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109540.9A HK1208809A1 (en) 2012-06-13 2015-09-29 Compositions and methods for enhancing the efficacy of contraceptive microbicides

Country Status (17)

Country Link
US (6) US20150202216A1 (de)
EP (2) EP2861215A4 (de)
JP (2) JP6352907B2 (de)
KR (1) KR102062599B1 (de)
CN (2) CN104487054A (de)
AP (1) AP2014008149A0 (de)
AU (2) AU2013274815B2 (de)
BR (1) BR112014030984B1 (de)
EA (1) EA201590008A1 (de)
HK (1) HK1208809A1 (de)
IL (1) IL235812B (de)
MX (2) MX365905B (de)
NZ (1) NZ703203A (de)
SG (1) SG11201408243VA (de)
UA (1) UA115876C2 (de)
WO (1) WO2013187984A1 (de)
ZA (1) ZA201500111B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2014008149A0 (en) 2012-06-13 2014-12-31 Evofem Inc Compositions and methods for enhancing the efficacy of contraceptive microbicides
BR112016014506B1 (pt) * 2013-12-19 2022-06-28 Evofem, Inc Composição para contraceptivo de tamponamento ácido à base de ácido algínico
AU2017338748A1 (en) * 2016-10-04 2019-05-02 Evofem Inc. Method of treatment and prevention of bacterial vaginosis
USD920853S1 (en) * 2018-09-14 2021-06-01 Porsche Lizenz—und Handelsgesellschaft mbH & Co. KG Bicycle
US11850303B2 (en) 2020-10-27 2023-12-26 Uqora, Inc. Gel and a suppository and methods to provide the gel and suppository

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4999342A (en) 1988-08-16 1991-03-12 Ortho Pharmaceutical Corporation Long lasting contraceptive suppository composition and methods of use
JP3202365B2 (ja) 1992-12-04 2001-08-27 株式会社紀文フードケミファ オリゴマンヌロン酸を重合度によって分離する方法
US5592949A (en) 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2728464B1 (fr) * 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
AU1661901A (en) 1999-11-24 2001-06-04 Cargill Dow Llc Improved lactic acid processing; methods; arrangements; and, products
PL202918B1 (pl) * 2000-03-07 2009-08-31 Rush Presbyterian St Luke Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie
JP2009102407A (ja) 2001-03-08 2009-05-14 Rohto Pharmaceut Co Ltd Ｇリッチなアルギン酸含有組成物
US20020177624A1 (en) 2001-03-16 2002-11-28 Calvin Hanna Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis
ITMI20010913A1 (it) 2001-05-04 2002-11-04 Univ Pavia Composizioni a rilascio controllato di acido lattico a livello vaginale
EP1399151A4 (de) 2001-06-11 2004-08-04 Merck & Co Inc Verfahren zur behandlung entzündlicher erkrankungen durch verabreichung eines ppar-delta-agonisten
US20060105008A1 (en) 2002-03-28 2006-05-18 Nawaz Ahmad Compositions and methods for reducing vaginal pH
US20130150810A1 (en) 2002-04-30 2013-06-13 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
WO2004011032A1 (ja) 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. 外用剤
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9241997B2 (en) 2003-06-13 2016-01-26 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
US20050272700A1 (en) 2004-05-10 2005-12-08 Servet Buyuktimkin Topical treatment and prevention of human papilloma virus (HPV) infection
RU2257197C1 (ru) 2004-05-12 2005-07-27 Дулькис Мария Дмитриевна Вагинальные суппозитории, обладающие контрацептивным действием
UA93354C2 (ru) * 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
WO2008056786A1 (fr) 2006-11-10 2008-05-15 Rohto Pharmaceutical Co., Ltd. Composition pour application cutanée ou par voie muqueuse
US7659259B2 (en) 2006-12-21 2010-02-09 Bausch & Lomb Incorporated Method of treating inflammation of the eye
WO2008119518A1 (en) 2007-03-30 2008-10-09 Laccure Ab Use of oligomers of lactic acid in the treatment of gynaecological disorders
JP2010528052A (ja) * 2007-05-24 2010-08-19 ニューヨーク ブラッド センター， インコーポレイテッド 生体接着性ジェルを提供する迅速に分散し得る膣錠剤
US8464245B2 (en) 2007-06-27 2013-06-11 Flexera Software Llc Method and system for software virtualization directly from an installation package
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
AU2009237478A1 (en) * 2008-04-16 2009-10-22 Cipla Limited Topical combinations comprising an antimycotic agent and an antiviral agent
CN101559036B (zh) * 2008-04-18 2012-02-08 上海医药工业研究院 一种阴道用避孕凝胶组合物及其制备方法和应用
WO2009155118A1 (en) 2008-05-30 2009-12-23 Reprotect, Inc. Compositions and methods for inactivation of pathogens at genital tract surfaces
EP2130531A1 (de) 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginalzäpfchen enthaltend Laktatsäure
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
US20120070476A1 (en) 2009-05-29 2012-03-22 Moench Thomas R Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
WO2010142761A1 (en) 2009-06-10 2010-12-16 Ultimorphix Technologies B.V. The succinate of tenofovir disoproxil
EP2704694A4 (de) 2011-05-02 2014-11-19 Aptalis Pharmatech Inc Schnell auflösende tablettenzusammensetzungen zur vaginalen verabreichung
CN103763925A (zh) 2011-06-28 2014-04-30 梅迪奇制药有限公司 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性阴道病的用途
NZ630347A (en) 2012-03-19 2016-04-29 Wolff August Gmbh & Co Kg Arzneimittel Dr Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
AP2014008149A0 (en) 2012-06-13 2014-12-31 Evofem Inc Compositions and methods for enhancing the efficacy of contraceptive microbicides
US20150246065A1 (en) 2012-09-14 2015-09-03 Cipla Limited Topical Pharmaceutical Composition
WO2015027071A1 (en) 2013-08-21 2015-02-26 Georgia Regents Research Institute, Inc. Gpr81 agonists and methods thereof for promoting production of secretory iga
WO2015070072A1 (en) 2013-11-07 2015-05-14 Evofem, Inc. Methods for manufacturing contraceptive microbicides with antiviral properties
BR112016014506B1 (pt) 2013-12-19 2022-06-28 Evofem, Inc Composição para contraceptivo de tamponamento ácido à base de ácido algínico
AU2015201042A1 (en) 2014-02-28 2015-09-17 Macfarlane Burnet Institute For Medical Research And Public Health Pty Ltd Therapeutic Method
WO2018049326A1 (en) 2016-09-12 2018-03-15 Evofem Biosciences, Inc. Combination gel for sexually transmitted infections
AU2017338748A1 (en) 2016-10-04 2019-05-02 Evofem Inc. Method of treatment and prevention of bacterial vaginosis

Also Published As

Publication number Publication date
US11439610B2 (en) 2022-09-13
US11992472B2 (en) 2024-05-28
BR112014030984A2 (pt) 2017-06-27
MX2014015307A (es) 2015-07-06
IL235812B (en) 2020-05-31
UA115876C2 (uk) 2018-01-10
CN104487054A (zh) 2015-04-01
US20150202216A1 (en) 2015-07-23
US9566232B2 (en) 2017-02-14
AP2014008149A0 (en) 2014-12-31
EA201590008A1 (ru) 2015-05-29
JP2018109034A (ja) 2018-07-12
US10568855B2 (en) 2020-02-25
JP6738573B2 (ja) 2020-08-12
CN110693812A (zh) 2020-01-17
US20160008276A1 (en) 2016-01-14
AU2017206199A1 (en) 2017-08-03
NZ703203A (en) 2016-07-29
US20230241013A1 (en) 2023-08-03
MX365905B (es) 2019-06-18
AU2013274815A1 (en) 2015-01-22
KR102062599B1 (ko) 2020-01-06
KR20150018636A (ko) 2015-02-23
JP6352907B2 (ja) 2018-07-04
US20170128396A1 (en) 2017-05-11
SG11201408243VA (en) 2015-01-29
MX2019007176A (es) 2019-08-16
EP2861215A1 (de) 2015-04-22
ZA201500111B (en) 2016-01-27
EP2861215A4 (de) 2015-04-22
EP3308771A1 (de) 2018-04-18
BR112014030984B1 (pt) 2022-05-24
AU2017206199B2 (en) 2019-03-28
AU2013274815B2 (en) 2017-04-20
JP2015519395A (ja) 2015-07-09
IL235812A0 (en) 2015-01-29
US20190133978A1 (en) 2019-05-09
US20200147015A1 (en) 2020-05-14
WO2013187984A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
IL266582A (en) Preparations and methods for the treatment of hemoglobin diseases
HK1226301A1 (zh) 修飾的治療劑及其組合物
HK1213798A1 (zh) 治療性化合物和組合物
HK1216175A1 (zh) 治療性化合物和組合物
IL235436A0 (en) Anti-pcsk9 preparations and their use
IL286759A (en) Therapeutic methods and preparations
HK1220920A1 (zh) 治療性組合物和其用途
EP2884984A4 (de) Therapeutische zusammensetzungen und verfahren
SG11201601625UA (en) Hypertonic antimicrobial therapeutic compositions
EP2935280A4 (de) 8'-hydroxy-dihydroergotamin-verbindungen und -zusammensetzungen
EP2806894A4 (de) Verfahren und zusammensetzungen für therapeutika
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
HK1208809A1 (en) Compositions and methods for enhancing the efficacy of contraceptive microbicides
ZA201408055B (en) Compositions and methods for the treatment of local pain
PL3041831T3 (pl) Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby
GB2516838B (en) Fungicidal compositions and their use
EP2895186A4 (de) Therapeutische zusammensetzungen und zugehörige verfahren
EP2834635A4 (de) Zusammensetzungen mit einem heparinakkumulationsmittel und verfahren dafür
GB201319255D0 (en) Therapeutic compositions and methods